Global Candida Infection Testing Market to Reach $21.3 Billion by 2029, Growing at 6.2% CAGR

What combination of drivers is leading to accelerated growth in the candida infection testing market?
The rising incidence of yeast infections is indeed contributing to the growth of the candida infection testing market. With an increasing number of yeast infections, especially those affecting sensitive areas of the body, the demand for accurate testing and diagnosis is growing. Testing for candida infection allows healthcare providers to appropriately identify and treat these infections, thus expanding the market for these diagnostic tools.

Get Your Candida Infection Testing Market Report Here:
https://www.thebusinessresearchcompany.com/report/candida-infection-testing-global-market-report

What is the projected compound annual growth rate (CAGR) of the candida infection testing market from 2025 to 2034, and what factors influence it?
The candida infection testing market is projected to expand from $15.69 billion in 2024 to $16.72 billion in 2025 at a CAGR of 6.6%, driven by a rising incidence of candida infections, increased diagnostic awareness, expanding healthcare infrastructure, growing hospital-acquired infections, and rising research funding.

The candida infection testing market is expected to grow significantly, reaching $21.29 billion by 2029 at a CAGR of 6.2%. Contributing factors include the emergence of new candida strains, greater awareness of fungal infections, expanded healthcare access, an aging population, and a stronger emphasis on preventive healthcare. Notable trends will include advancements in molecular diagnostics, the integration of digital health technologies, the adoption of AI and machine learning, and the increasing focus on personalized medicine.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19356&type=smp

How are the latest trends influencing the growth of the candida infection testing market?
In the candida infection testing market, companies are advancing fully automated PCR rapid tests to enhance diagnostic accuracy. For example, in May 2024, Bosch Healthcare Solutions GmbH, a Germany-based medical technology manufacturer, launched a PCR test for Candida auris detection on its Vivalytic platform. This fully automated rapid test provides results in under an hour, offering faster diagnosis compared to traditional methods, which can take several days.

What are the major segments of the candida infection testing market and their role in driving growth?
The candida infection testingmarket covered in this report is segmented -

1) By Type: Invasive Candidiasis, Candidemia
2) By Test Type: Vaginal pH Test, Nucleic Acid Amplification Testing (NAAT), Microbiome Test
3) By Application: Hospital, Laboratory

Subsegments:
1) By Invasive Candidiasis: Tissue Biopsy Testing, Urine Culture Testing, Blood Culture Testing
2) By Candidemia: Blood Tests, Serological Testing, Molecular Testing

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19356

Which regions are key players in the growth of the candida infection testing market?
North America was the largest region in the candida infection testing market in 2024. The regions covered in the candida infection testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Who are the key firms paving the way for growth in the candida infection testing market?
Major companies operating in the candida infection testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers AG, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Hologic Inc., bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, QIAGEN N.V., Cepheid, Randox Laboratories Ltd., Meridian Bioscience Inc., DiaSorin S.p.A., Sekisui Diagnostics LLC, Enzo Biochem Inc., T2 Biosystems Inc., Aidian Oy, SafeCare LLC, CHROMagar, HK Biotek Inc., Health Testing Centers LLC, Accesa Labs LLC, Private MD Labs LLC

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=19356&type=smp

What Is Covered In The Candida Infection Testing Global Market Report?

•Market Size Forecast: Examine the candida infection testing market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the candida infection testing market for a structured understanding.
•Key Players Overview: Analyze major players in the candida infection testing market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the candida infection testing market.
•Segment Contributions: Evaluate how different segments drive overall growth in the candida infection testing market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the candida infection testing market.
•Industry Challenges: Identify potential risks and obstacles affecting the candida infection testing market.
•Competitive Landscape: Review strategic developments in the candida infection testing market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.